Abstract

Down’s syndrome is the most common type of chromosomal abnormality found in neonates. It is associated with characteristic abnormal facial features and mental retardation. However, clinical diagnosis is not sufficient to confirm the disease. Classical karyotyping has long been used as diagnostic tool for confirming Down’s syndrome. The present study was conducted to confirm the cytogenetic composition of individuals suspected with Down’s syndrome after the preliminary clinical diagnosis in Basra, Iraq. Karyotype analysis was carried out for 249 suspected cases of Down’s syndrome. 249 patients were confirmed to have Down’s syndrome after cytogenetic tests. Nearly 90% of these patients had pure trisomy 21 and about 5% of cases had translocations. Less than 4% of cases were reported having mosaic trisomy and only 1.4% patients carried additional chromosomal abnormalities. In our study, the disease showed significant gender bias, with an excess of males than females (sex ratio was 1.39). The identification of specific chromosomal abnormalities in different variants of Down’s syndrome patients work as first step towards improving their quality of life. The study also provides the basic information required to forecast the various complications associated with Down’s syndrome.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call